| scholarly article | Q13442814 |
| P50 | author | Søren Brunak | Q7666528 |
| Niels E. Skakkebæk | Q12328758 | ||
| Agnieszka Sierakowska Juncker | Q42577755 | ||
| Lise Mette Gjerdrum | Q47367382 | ||
| Si Brask Sonne | Q47367399 | ||
| Ewa Rajpert-De Meyts | Q47367417 | ||
| Marlene D Dalgaard | Q96952697 | ||
| Henrik Leffers | Q114439668 | ||
| Kristian Almstrup | Q38548487 | ||
| P2093 | author name string | Peter W Andrews | |
| Amir Abdollahi | |||
| Peter E Huber | |||
| Harry D Moore | |||
| Christian Schwager | |||
| Ludmila Ruban | |||
| Neil J Harrison | |||
| Daniel Edsgard | |||
| P2860 | cites work | Intermediate filament proteins in human testis and testicular germ-cell tumors. | Q42752909 |
| A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis. | Q45239019 | ||
| Germ cell differentiation-dependent and stage-specific expression of LANCL1 in rodent testis. | Q48186528 | ||
| A receptor-type protein tyrosine phosphatase PTP zeta is expressed in human cutaneous melanomas. | Q52169238 | ||
| Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. | Q52173957 | ||
| Light and electron microscopical analysis of cell types in human seminoma. | Q54072426 | ||
| Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. | Q54709833 | ||
| Gene expression profiling identifies new biological markers of neoplastic germ cells | Q58194332 | ||
| Co-expression of cytokeratin and vimentin filaments in mesothelial, granulosa and rete ovarii cells of the human ovary | Q58439218 | ||
| Genome profiles of familial/bilateral and sporadic testicular germ cell tumors | Q59273315 | ||
| Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours | Q60501370 | ||
| Aneuploidy as a marker for carcinoma-in-situ of the testis | Q70748539 | ||
| Carcinoma-in-situ of the undescended testis | Q72540601 | ||
| Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas | Q73322458 | ||
| Possible carcinoma-in-situ of the testis | Q93727453 | ||
| Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester | Q24293254 | ||
| Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms | Q24317415 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| Multiclass classification of microarray data with repeated measurements: application to cancer | Q24793866 | ||
| Fetal antigen 1, an EGF multidomain protein in the sex hormone-producing cells of the gonads and the microenvironment of germ cells | Q28145426 | ||
| Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours | Q28258587 | ||
| TM4: a free, open-source system for microarray data management and analysis | Q29547339 | ||
| Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects | Q29615676 | ||
| Expression of protamine-1 and -2 mRNA during human spermiogenesis | Q30842604 | ||
| High-resolution comparative genomic hybridization detects extra chromosome arm 12p material in most cases of carcinoma in situ adjacent to overt germ cell tumors, but not before the invasive tumor development | Q30978523 | ||
| Role of gain of 12p in germ cell tumour development | Q33187052 | ||
| Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. | Q33204298 | ||
| FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). | Q33324250 | ||
| Optimizing staining protocols for laser microdissection of specific cell types from the testis including carcinoma in situ | Q33444788 | ||
| Genetics and biology of adult human male germ cell tumors. | Q33882329 | ||
| Carcinoma in situ in the testis | Q34122634 | ||
| POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors | Q34194341 | ||
| Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads | Q34315876 | ||
| Identification and characterization of ASXL3 gene in silico. | Q34320220 | ||
| Identification, characterization, and evolution of a primate beta-defensin gene cluster | Q34623458 | ||
| Generation of pluripotent stem cells from adult human testis. | Q34851175 | ||
| The emerging phenotype of the testicular carcinoma in situ germ cell | Q35129514 | ||
| Early manifestations of testicular dysgenesis in children: pathological phenotypes, karyotype correlations and precursor stages of tumour development | Q35132939 | ||
| Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers | Q36492858 | ||
| The stem cell identity of testicular cancer | Q36943376 | ||
| Testicular dysgenesis syndrome and the origin of carcinoma in situ testis | Q37060508 | ||
| Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects | Q37097242 | ||
| Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development | Q38324122 | ||
| Dysfunction of the mitotic:meiotic switch as a potential cause of neoplastic conversion of primordial germ cells | Q40319110 | ||
| Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. | Q40476342 | ||
| Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells | Q40544422 | ||
| Anti-MIC2 as a tool in examination of testicular biopsies | Q40802345 | ||
| Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study | Q41545531 | ||
| Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. | Q41664542 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5241-5250 | |
| P577 | publication date | 2009-06-02 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte | |
| P478 | volume | 69 |
| Q41434285 | A genome-wide association study of men with symptoms of testicular dysgenesis syndrome and its network biology interpretation |
| Q37688873 | A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment. |
| Q34247366 | A unique combination of male germ cell miRNAs coordinates gonocyte differentiation |
| Q34692315 | An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism |
| Q39781684 | Analysis of SOX2 expression in developing human testis and germ cell neoplasia |
| Q24296808 | Analysis of meiosis regulators in human gonads: a sexually dimorphic spatio-temporal expression pattern suggests involvement of DMRT1 in meiotic entry |
| Q90208432 | Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours |
| Q38838783 | Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives |
| Q39949220 | Baldness and testicular cancer: the EPSAM case-control study |
| Q54598067 | Cancer testis antigen expression in testicular germ cell tumorigenesis. |
| Q42007600 | Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells |
| Q34464888 | Cellular and molecular effect of MEHP Involving LXRα in human fetal testis and ovary. |
| Q38172901 | Cellular evidence for selfish spermatogonial selection in aged human testes |
| Q35021459 | Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential |
| Q38883739 | Comparison of global gene expression profiles of microdissected human foetal Leydig cells with their normal and hyperplastic adult equivalents |
| Q41820355 | Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors. |
| Q43009263 | Cryptorchidism: pathogenesis, diagnosis, treatment and prognosis |
| Q36868543 | Current Management of Undescended Testes |
| Q33783200 | Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. |
| Q37288260 | Developmental reprogramming of cancer susceptibility |
| Q33896475 | Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance |
| Q45720545 | Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ |
| Q39367088 | Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cells. |
| Q34396787 | Etiologic factors in testicular germ-cell tumors |
| Q41918113 | Evidence that active demethylation mechanisms maintain the genome of carcinoma in situ cells hypomethylated in the adult testis |
| Q40447381 | Genomic evolution and chemoresistance in germ-cell tumours. |
| Q39082280 | Germ cell tumors: Insights from the Drosophila ovary and the mouse testis |
| Q39669544 | Heterochromatin marks HP1γ, HP1α and H3K9me3, and DNA damage response activation in human testis development and germ cell tumours |
| Q33940047 | Heterozygous deletion at the RLN1 locus in a family with testicular germ cell cancer identified by integrating copy number variation data with phenome and interactome information |
| Q37383318 | Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors. |
| Q36715639 | Induction and persistence of abnormal testicular germ cells following gestational exposure to di-(n-butyl) phthalate in p53-null mice. |
| Q38555758 | Intratubular Germ Cell Neoplasia of the Testis, Bilateral Testicular Cancer, and Aberrant Histologies. |
| Q37763851 | Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options |
| Q38861307 | Investigational targeted therapies for the treatment of testicular germ cell tumors |
| Q38535583 | Involvement of epigenetic modifiers in the pathogenesis of testicular dysgenesis and germ cell cancer |
| Q51820656 | Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours. |
| Q48229862 | Is the FSHR 2039A>G variant associated with susceptibility to testicular germ cell cancer? |
| Q33502381 | Laser capture microdissection of gonads from juvenile zebrafish. |
| Q34502168 | Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility |
| Q30904724 | Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union |
| Q91660922 | Management, Treatment, and Molecular Background of the Growing Teratoma Syndrome |
| Q40163628 | Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor. |
| Q39646985 | NANOG promoter methylation and expression correlation during normal and malignant human germ cell development |
| Q38984619 | OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia |
| Q93062279 | On the Origin of Testicular Germ Cell Tumors: From Gonocytes to Testicular Cancer |
| Q33444788 | Optimizing staining protocols for laser microdissection of specific cell types from the testis including carcinoma in situ |
| Q33930933 | Organochlorine compounds and testicular dysgenesis syndrome: human data |
| Q40046878 | Parental Occupational Exposure to Organic Solvents and Testicular Germ Cell Tumors in their Offspring: NORD-TEST Study |
| Q34378988 | Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors |
| Q38366531 | Recent adverse trends in semen quality and testis cancer incidence among Finnish men. |
| Q35617326 | Retinoblastoma protein (RB1) controls fate determination in stem cells and progenitors of the mouse male germline. |
| Q36289256 | Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant |
| Q57809760 | Sperm imprinting integrity in seminoma patients? |
| Q41077105 | Spontaneous CD4+ and CD8+ T-cell responses directed against cancer testis antigens are present in the peripheral blood of testicular cancer patients |
| Q47231034 | Testicular cancer from diagnosis to epigenetic factors |
| Q38184375 | Testicular cancer: biology and biomarkers |
| Q86879831 | Testicular germ cell tumours |
| Q38410131 | Testicular germ cell tumours in dogs are predominantly of spermatocytic seminoma type and are frequently associated with somatic cell tumours |
| Q37337141 | The Homeobox Transcription Factor RHOX10 Drives Mouse Spermatogonial Stem Cell Establishment |
| Q38975123 | The biology of germ cell tumors in disorders of sex development |
| Q38756704 | The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas |
| Q39180884 | The chemokine CXCL12 and its receptor CXCR4 are implicated in human seminoma metastasis |
| Q39154300 | The plasticity of germ cell cancers and its dependence on the cellular microenvironment. |
| Q37513681 | The rise of testicular germ cell tumours: the search for causes, risk factors and novel therapeutic targets. |
| Q37874665 | The role of BLIMP1 and its putative downstream target TFAP2C in germ cell development and germ cell tumours. |
| Q39408223 | The role of vitamin D in male fertility: A focus on the testis |
| Q37886262 | The testicular germ cell tumour transcriptome |
| Q41498099 | Transcriptome profiling of mice testes following low dose irradiation |
| Q38145508 | Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer. |
| Q52725335 | Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer. |
| Q29392883 | Vitamin D and male reproduction |
| Q42407720 | Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo |
| Q39762519 | Will Testicular Germ Cell Tumors Remain Untargetable? |
| Q26992374 | miRNA and mammalian male germ cells |
Search more.